CrunchBase is hiring! Check out our open positions →

Exit
edit

Acquired by	BioMarin Pharmaceutical
Price	$115M
Date	8/10

General Information
edit

Website	zystor.com
Category	BioTech
Phone	414-727-9777
Email	info@zystor.com
Employees

Offices
edit

Milwaukee, USA

10437 Innovation Drive, Suite 100
Milwaukee, WI, 53226
USA

Tags
edit

Zystor
edit

ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal storage diseases.

Recent Milestones
edit

Zystor was acquired by BioMarin Pharmaceutical for $115M. (8/18/10)

Posted 8/18/10 at 10:09am via fiercebiotech.com

Videos

Screenshots
edit

Sources

BioMarin snares orphan drug upstart in $115M buyout (fiercebiotech.com) [edit]

Edit This Page
Last Edited 8/18/10

Revision History

Sharing

External Links

edit

CrunchBase API

JSON Representation of this page.
More API docs »

Exit edit

General Information edit

Offices edit

Tags edit

Zystor edit

Recent Milestones edit